4601 - 4625 of 8587 Results
Title
Year
- Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein2021OPENTitle: Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synucleinJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01283-7Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-021-01283-7Citation Count: 21
-
OPENTitle: The neuro-toxin MPTP does not prevent reproduction in marmosetsJournal Name: MNI Open ResearchPublisher: F1000 Research LtdVol: 3Issue #:Start Page: 2End Page: 2Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.12688/mniopenres.12818.2Best OA location URL: https://mniopenresearch.org/articles/3-2/v2/pdfCitation Count: 0
-
OPENTitle: Measurement of chemosensory functionJournal Name: World Journal of Otorhinolaryngology - Head and Neck SurgeryPublisher: WileyVol: 4Issue #: 1Start Page: 11End Page: 28Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.wjorl.2018.03.001Best OA location URL: https://www.sciencedirect.com/science/article/pii/S2095881118300222?via%3DihubCitation Count: 55
- Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies2019OPENTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7061324Citation Count: 35
-
OPENTitle: Gender Differences in the Prevalence of Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 1Start Page: 86End Page: 93Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13584Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13584Citation Count: 41
- Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement2021RESTRICTEDTitle: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementJournal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Publisher: Walter de Gruyter GmbHVol: 59Issue #: 10Start Page: 1653End Page: 1661Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/cclm-2020-1521Citation Count: 6
-
OPENTitle: A high-resolution map of the human small non-coding transcriptomeJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 34Issue #: 10Start Page: 1621End Page: 1628Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/bioinformatics/btx814Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/34/10/1621/25118245/btx814.pdfCitation Count: 26
- Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates2017OPENTitle: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s40478-017-0451-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0451-7Citation Count: 40
- Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegeneration2025OPENTitle: Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegenerationJournal Name: Fluids and Barriers of the CNSPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12987-025-00646-9Best OA location URL: https://fluidsbarrierscns.biomedcentral.com/counter/pdf/10.1186/s12987-025-00646-9Citation Count: 0
- LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients2019OPENTitle: LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patientsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-13413-wBest OA location URL: https://www.nature.com/articles/s41467-019-13413-w.pdfCitation Count: 170
- Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease2018OPENTitle: Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 19Issue #:Start Page: 1025End Page: 1035Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.006Best OA location URL: https://doi.org/10.1016/j.nicl.2018.05.006Citation Count: 53
- Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications2023OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645.2Best OA location URL: https://cdn.elifesciences.org/articles/91645/elife-91645-v2.pdfCitation Count: 28
- SWATH-MS proteome profiling data comparison of DJ-1, Parkin, and PINK1 knockout rat striatal mitochondria2016OPENTitle: SWATH-MS proteome profiling data comparison of DJ-1, Parkin, and PINK1 knockout rat striatal mitochondriaJournal Name: Data in BriefPublisher: Elsevier BVVol: 9Issue #:Start Page: 589End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.dib.2016.09.031Best OA location URL: https://doi.org/10.1016/j.dib.2016.09.031Citation Count: 12
-
OPENTitle: Genome-Wide Association Study of Glucocerebrosidase Activity ModifiersJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 62Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-025-04996-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-025-04996-1.pdfCitation Count: 0
-
OPENTitle: GBA variation and susceptibility to multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 64End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.007Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.06.007Citation Count: 20
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities2021OPENTitle: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunitiesJournal Name: Physiology NewsPublisher: The Physiological SocietyVol:Issue #: Autumn 123Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.36866/123.32Best OA location URL: https://static.physoc.org/app/uploads/2021/09/29101854/PN123_2709_WEB_FINAL.pdfCitation Count: 0
- Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease2022OPENTitle: Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00300-3Best OA location URL: https://www.nature.com/articles/s41531-022-00300-3.pdfCitation Count: 25
- Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental Approach2024OPENTitle: Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental ApproachJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 26Issue #: 1Start Page: 9End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms26010009Best OA location URL: https://www.mdpi.com/1422-0067/26/1/9/pdf?version=1735026493Citation Count: 4
-
OPENTitle: Stiripentol for the treatment of super-refractory status epilepticusJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 132Issue #: 6Start Page: 435End Page: 439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12403Best OA location URL: https://doi.org/10.1111/ane.12403Citation Count: 42
- Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial2024OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Best OA location URL: https://www.nature.com/articles/s41591-024-03101-8.pdfCitation Count: 13
-
RESTRICTEDTitle: Expert comment: “A case of missing pathology in a patient with LRRK2 Parkinson's disease”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 74Issue #:Start Page: 78End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.005Citation Count: 3
- Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum2016OPENTitle: Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrumJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 46Issue #:Start Page: 32End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.06.003Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2016.06.003Citation Count: 22
-
OPENTitle: Association of mitochondrial genomic background with risk of Multiple System AtrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 200End Page: 204Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.040Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7769955Citation Count: 6
-
OPENTitle: Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast CancerJournal Name: Journal of OncologyPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/5899728Best OA location URL: https://escholarship.org/content/qt9cj1h6h9/qt9cj1h6h9.pdfCitation Count: 1
-
OPENTitle: Cerebral chemoarchitecture shares organizational traits with brain structure and functionJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.83843Best OA location URL: https://cdn.elifesciences.org/articles/83843/elife-83843-v2.pdfCitation Count: 13